Navigation Links
DNA technique measures suitability of soil for onion crops

Nematodes, such as the stem nematode, and fungi, such as white rot, are particularly harmful for onion crops in the Netherlands: they cause rot. Soil samples are investigated to detect this; a labour-intensive and expensive operation. Together with the Laboratory for Nematology (University of Wageningen) the company Blgg has developed a molecular technique to detect the stem nematode and white rot in soil samples.

Agricultural laboratory Blgg will start using the new system in November 2005. The system quickly and accurately measures soil samples at the molecular level. In a series of comparative trials, the molecular test had a higher detection rate than the traditional microscopic investigation for both the stem nematode and onion white rot.

Each year thousands of soil samples are investigated for their suitability for onion crops. They are examined for the presence of the nematode Ditylenchus dipsaci (the stem nematode) and the fungus Sclerotium cepivorum (onion white rot). For years this has been done visually under the microscope; a specialised and labour-intensive process.

Blgg director Henri Hekman had been looking for a more accurate, faster and cheaper method for some time. He came into contact with Wageningen researcher Hans Helder who, with funding from Technology Foundation STW, was compiling a DNA database of all nematode species in the Netherlands. This database, together with a method for the easy extraction of DNA from nematodes, forms the basis for the technique developed to detect harmful nematodes. The Technology Foundation STW filed a patent for this technology, and this patent was recently transferred to Blgg.

In close cooperation with the Laboratory for Nematology, Blgg managed to successfully combine the fundamental knowledge from the patent with state-of-the-art laboratory practice. The result is a practical test that conclusively demonstrates the presence of both the stem nematode and onion white rot.


'"/>

Source:Netherlands Organization for Scientific Research


Page: 1 2

Related biology news :

1. New lab technique identifies high levels of pathogens in therapy pool
2. Brain-mapping technique aids understanding of sleep, wakefulness
3. Study reveals new technique for fingerprinting environmental samples
4. Researchers pioneer new gene therapy technique using natural repair process
5. Newer imaging techniques may lead to over-treatment
6. Gene silencing technique offers new strategy for treating, curing disease
7. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
8. Researchers devise new technique for creating human stem cells
9. New technique rapidly detects illness-causing bacteria
10. New bioinformatics technique for systematically analyzing key regions in DNA that help control gene activity
11. New technique may speed DNA analysis
Post Your Comments:
(Date:12/3/2009)...rctic snowmelt that occurred during the 2008-09 au...ositive phases for two main climate drivers, ENSO ...Hemisphere Annular Mode), according to Dr. Marco T... Sciences at The City College of New York. , P...lty at the CUNY Graduate Center, added that Antarc...
(Date:12/2/2009)...moke their first cigarette within minutes after wa...product of nicotine when processed by the body, th...er of cigarettes smoked. , "Since cotinine le...r results suggest that smokers who smoke immediate... cancer," said researcher Joshua E. Muscat, Ph.D.,...
(Date:12/2/2009)...ut butter, and other foods have done more than rai... They also are quietly fueling a boom in the marke...d safety regulations. That,s the topic of the two-... & Engineering News , (C&EN) ACS, weekly newsmagaz... Senior Correspondent Marc Reisch point out that f...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Increased nicotine levels detected in those who light-up earlier 2Top Healthcare Magazine Awards Carefx Client 2009 IT Project of the Year 53045 1Top Healthcare Magazine Awards Carefx Client 2009 IT Project of the Year 53045 2Top Healthcare Magazine Awards Carefx Client 2009 IT Project of the Year 53045 3Hospira Reports Second Quarter 2009 Results 53042 1Hospira Reports Second Quarter 2009 Results 53042 2Hospira Reports Second Quarter 2009 Results 53042 3Hospira Reports Second Quarter 2009 Results 53042 4Hospira Reports Second Quarter 2009 Results 53042 5Hospira Reports Second Quarter 2009 Results 53042 6Hospira Reports Second Quarter 2009 Results 53042 7Hospira Reports Second Quarter 2009 Results 53042 8Hospira Reports Second Quarter 2009 Results 53042 9Hospira Reports Second Quarter 2009 Results 53042 10Hospira Reports Second Quarter 2009 Results 53042 11Hospira Reports Second Quarter 2009 Results 53042 12Hospira Reports Second Quarter 2009 Results 53042 13Hospira Reports Second Quarter 2009 Results 53042 14Hospira Reports Second Quarter 2009 Results 53042 15Hospira Reports Second Quarter 2009 Results 53042 16Hospira Reports Second Quarter 2009 Results 53042 17Hospira Reports Second Quarter 2009 Results 53042 18Hospira Reports Second Quarter 2009 Results 53042 19Hospira Reports Second Quarter 2009 Results 53042 20Hospira Reports Second Quarter 2009 Results 53042 21Hospira Reports Second Quarter 2009 Results 53042 22Hospira Reports Second Quarter 2009 Results 53042 23Hospira Reports Second Quarter 2009 Results 53042 24Hospira Reports Second Quarter 2009 Results 53042 25Hospira Reports Second Quarter 2009 Results 53042 26Hospira Reports Second Quarter 2009 Results 53042 27Hospira Reports Second Quarter 2009 Results 53042 28STAAR Surgical to Present at BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York 53040 1
...t endangered cat, the Amur or Far Eastern leopard ... 25 to 34 are left in the wild, renewing fears for...h, World Wildlife Fund along with the Wildlife Con...graphy of the Russian Academy of Science, conducte... , "The recent census confirmed once again that ...
...e an adverse effect on an adult’s performance at w...an also have a negative impact on how well middle ... A study published in the February 15th issue of t... that adolescents who experience sleep disturbance... , James F. Pagel, MD, of the University of Colora...
...y low virus concentration or a sample of water for...ming and difficult process. Researchers at the Geo...have developed an easier and faster method to dete...es using highly porous, micron-sized, silica beads...ultaneously or sequentially add optical and magnet...
Other Biology News:Amur leopard still on the brink of extinction, scientists say 2Sleep disturbances affect classroom performance 2Scientists create dual-modality microbeads to improve identification of disease biomarkers 2Scientists create dual-modality microbeads to improve identification of disease biomarkers 3
(Date:12/4/2009)...IRVINE, Calif., Dec. 4 B...FRE), a company focused on changing the world,s tr...of ethanol from non-food cellulosic wastes, has be...of the "50 Hottest Companies in Bioenergy;" the co..., "Having voters rank BlueFire Ethanol among the...
(Date:12/3/2009)...AN FRANCISCO, Dec. 3 VIA...nology company focused on the development of compo...olic disease, today announced that it has complete...inical trial of VIA-2291. ,, The FDG-PET trial...sites in the US and Canada including Massachusetts...
(Date:12/3/2009)...HOPKINTON, Mass., Dec. 3 ...eading provider of tools and services for drug dis...d Living Image 4.0 software for IVIS® in vivo... more than 800 Caliper IVIS systems currently inst...features advanced spectral unmixing tools to enhan...
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.... available in its catalogue: ,, Neurostimulati...w.reportlinker.com/p0164232/Neurostimulation---A-G...urostimulation market stands enthused by the growi...e in age-related diseases such as, Parkinson,s, an...
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6
...poration (OTC: CGCP), announced that the company w...ptember 30, 2007 prior to market open on,Wednesday...esident Richard,P. Lanigan and Senior Vice Preside...ill host an investor conference call that day at 1... review the company,s financial results and,busine...
...Inc. (CTI) (Nasdaq and MTAX: CTIC) announced precl...EORTC Symposium show its bis-platinate drug,candid...y to currently,marketed platinum agents carboplati...d enter human clinical trials in late 2008. "Bis-...inum-based,chemotherapy drugs with a potential bro...
...Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, N... letter of approval from the U.K. Medicines and He... Clinical Trial Application (CTA) to begin,a clini...YSIN(R) in,combination with cyclophosphamide, a ch...in patients with advanced cancers. The Principal,I...
Other Biology Technology:Cardiogenesis Corporation to Report Third Quarter 2007 Results on November 14th 2First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs 2First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs 3Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide 2Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide 3
8453 UV-Visible Spectrophotometer from Agilent Technologies
... monoclonal [RS17 ] to PRKAR2 cAMP is a signaling...tions. cAMP exerts its effects by activating the c...ces the signal through phosphorylation of differen... is a tetramer composed of two regulatory and two ...
SolidSpec-3700 UV-VIS-NIR Spectrophotometer from Shimadzu
UltraVIEW Upgrade from Andor Technology
Biology Products: